1.
Cesk Patol
; 58(3): 135-137, 2022.
Artículo
en Inglés
| MEDLINE
| ID: mdl-36224035
RESUMEN
The new WHO classification of CNS tumors is largely based on molecular diagnostic. Without molecular methods some entities can no longer be diagnosed. We are trying to show a rational approach to the CNS tumors diagnostics, which is based on conventional molecular methods such as RT-PCR, Sanger sequencing, MLPA, extended by the next generation sequencing (NGS) and methylation SNP array.